Author:
Altamura A. C.,Montgomery S. A.,Wernicke J. F.
Abstract
Fluoxetine, a selective serotonin-uptake inhibitor, has been shown to be effective in the treatment of depression. A series of studies found fluoxetine to be more effective than placebo and to be associated with equivalent efficacy to standard reference tricyclic antidepressants (Stark & Hardison, 1985; Feighner & Cohn, 1985).The selection of a dosage regime for fluoxetine in these studies was based on the information gathered from open dose-ranging investigations. In these studies, treatment starts with one dose level, which is then increased as indicated in the protocol or until increased doses are not tolerated due to side-effects. One of the weaknesses in this method of choosing the likely standard dose of a new antidepressant lies in the inherent bias towards the selection of the higher dose levels. This is particularly true for drugs which are well tolerated.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Reference10 articles.
1. 5-HT reuptake inhibitors plus tryptophan in endogenous depression
2. A fixed-dose clinical trial of fluoxetine in out-patients with major depression;Fabre;Journal of Clinical Psychiatry,1987
3. Dornseif B. E. , Wernicke J. F. , Dunlop S. R. & Potvin J. H. (1988) Effect of dose escalation after low-dose fluoxetine therapy. Presented at New Clinical Drug Evaluation Unit, June 1988.
4. Fixed-dose fluoxetine therapy for depression;Wernicke;Psychopharmacological Bulletin,1987
5. A double blind comparison of zimelidine and amitriptyline in endogenous depression
Cited by
84 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献